Perceptive Advisors’s Elevance Health ELV Stock Holding History

Perceptive Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,081	Closed	-$510K	–	144
2017 Q1	$510K	Buy	+3,081	New	+$490K	0.03%	120
2016 Q4	–	Sell	-3,400	Closed	-$426K	–	198
2016 Q3	$426K	Hold	3,400	–	–	0.03%	142
2016 Q2	$447K	Sell	3,400 -347	-9%	-$47.5K	0.03%	131
2016 Q1	$521K	Buy	+3,747	New	+$501K	0.05%	117
2015 Q4	–	Sell	-1,436	Closed	-$201K	–	161
2015 Q3	$201K	Hold	1,436	–	–	0.02%	130
2015 Q2	$236K	Buy	+1,436	New	+$229K	0.01%	152
2014 Q4	–	Sell	-901	Closed	-$108K	–	157
2014 Q3	$108K	Buy	+901	New	+$103K	0.01%	115
2013 Q3	–	Sell	-255	Closed	-$21K	–	112
2013 Q2	$21K	Buy	+255	New	+$19.1K	﹤0.01%	75

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Perceptive Advisors's ELV Position: Q2 2017 in Review

Perceptive Advisors sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 3,081 shares — an estimated $510K sold.

Perceptive Advisors first reported a position in ELV in Q2 2013 and held it in 8 quarters. The position peaked at $521K in Q1 2016. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Perceptive Advisors reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
Perceptive Advisors sold 3,081 Elevance Health shares in Q2 2017, an estimated $510K.
Perceptive Advisors first reported a position in Elevance Health in Q2 2013 and held it in 8 quarters.
Perceptive Advisors's Elevance Health position peaked at $521K in Q1 2016.
852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.